Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 and ED95 of remimazolam for adjunctive sedation in elderly patients under spinal anesthesia
ChiCTR2100051912Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Hainan Medical University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in prostate disease and Perioperative anxiety, sponsored by Second Affiliated Hospital of Hainan Medical University. Primary endpoints: Modified Assessment of Alertness/Sedation score, Mean arterial pressure and 5 more. Started Oct 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
prostate diseasePerioperative anxiety
Beyond the preview
Go deeper on ChiCTR2100051912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051912.